Skip to main content
Premium Trial:

Request an Annual Quote

Tina Nova

Veracyte said this week that it has appointed Tina Nova to its board of directors. She currently serves as president and CEO of molecular diagnostics firm Molecular Stethoscope, and she previously has served as senior VP and general manager of Illumina's oncology business unit. Nova also was a co-founder, director, president, and CEO of Genoptix Medical Laboratory, which was acquired by Novartis Pharmaceuticals in 2011. She serves on the board of directors of Arena Pharmaceuticals and is vice chairman of the board of directors for the Rady Pediatric Genomics and Systems Medicine Institute.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.